{
    "Trade/Device Name(s)": [
        "Alere\u2122 PBP2a SA Culture Colony Test",
        "Alere\u2122 SA PBP2a Test",
        "Alere\u2122 PBP2a Staphylococcus aureus Test",
        "Alere\u2122 Culture Colony Test"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K133851",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011710"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYI"
    ],
    "Summary Letter Date": "August 13, 2014",
    "Summary Letter Received Date": "August 20, 2014",
    "Submission Date": "August 14, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Penicillin-binding protein 2a (PBP2a)"
    ],
    "Specimen Type(s)": [
        "Isolates identified as Staphylococcus aureus"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative immunochromatographic membrane assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Alere PBP2a SA Culture Colony Test, a rapid immunochromatographic assay to detect penicillin-binding protein 2a (PBP2a) in Staphylococcus aureus isolates as an aid in identifying MRSA.",
    "Indications for Use Summary": "Qualitative, in vitro immunochromatographic assay for rapid detection of penicillin-binding protein 2a (PBP2a) in Staphylococcus aureus isolates to aid in identifying methicillin-resistant Staphylococcus aureus (MRSA).",
    "fda_folder": "Microbiology"
}